2 completed, 2 terminated, 2 unknown, 1 available. 4 Phase 2, 1 Early Phase 1, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Unknown 2, Completed 1, Terminated 1 |
| Early Phase 1 | 1 | Terminated 1 |
| Phase 1 | 1 | Completed 1 |
Follow Bellerophon: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Inhaled Nitric Oxide for Preventing Progression in COVID-19 Nitric Oxide - COVID-19 | Phase 2 | Terminated | Tufts Medical Center | 10 | 2020-05-12 | 2022-04-19 |
| Inhaled NO in IPF and COPD During 6 Minute Walk Test Inhaled nitric oxide - COPD, IPF | Phase 2 | Unknown | Rabin Medical Center | 100 | 2019-03-04 | 2019-12-26 |
| A Dose Escalation Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis or Sarcoidosis iNO - Pulmonary Hypertension, Pulmonary Fibrosis | Phase 2 | Completed | Bellerophon | 17 | 2019-01-30 | 2022-08-10 |
| A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis INOpulse®, Placebo, Long Term Follow Up - Pulmonary Fibrosis, Pulmonary Hypertension | Phase 2 | Unknown | Bellerophon | 85 | 2017-12-29 | 2023-02-28 |
| Effect iNO on Functional Respiratory Imaging in Subjects With WHO Group 3 Pulmonary Hypertension With COPD on Oxygen Inhaled Nitric Oxide 30mcg/kg IBW/hr - COPD, Pulmonary Hypertension | Early Phase 1 | Terminated | Bellerophon | 7 | 2016-10-01 | 2023-02-21 |
| 3 Part Study to Assess Inhaled Nitric Oxide on Functional Pulmonary Imaging in Subj. Pulmonary Hypertension Associated w/ COPD and IPF inhaled Nitric Oxide - 30 mcg/kg IBW/hr, inhaled Nitric Oxide 5,10,15 mcg/Kg IBW/hr, inhaled nitric oxide 75 mcg/kg IBW/hr - Pulmonary Hypertension, Chronic Obstructive Pulmonary Disease | Phase 1 | Completed | Bellerophon | 8 | 2015-05-01 | 2023-02-21 |
| Expanded Access for Patients With Pulmonary Hypertension Associated With Pulmonary Fibrosis INOpulse - Pulmonary Fibrosis, Pulmonary Hypertension | Available | Bellerophon | 2023-02-21 | |||
| Pulsed Inhaled Nitric Oxide for the Treatment of Patients With Mild or Moderate COVID-19 iNO (inhaled nitric oxide) delivered via the INOpulse Delivery System - Coronavirus Infection, COVID-19 | No longer available | Bellerophon | 2023-02-21 |
Hypertension, Pulmonary (5) · Pulmonary Disease, Chronic Obstructive (3) · Pulmonary Fibrosis (3) · COVID-19 (2) · Coronavirus Infections (1) · Idiopathic Pulmonary Fibrosis (1) · Pneumonia (1) · Pneumonia, Viral (1) · Sarcoidosis (1) · Sarcoidosis, Pulmonary (1) · Severe Acute Respiratory Syndrome (1) · Virus Diseases (1)
Inosine (2) · Nitric Oxide (1)
United States (3) · Belgium (2) · Israel (1)
Ashika Ahmed, MD (4) · Ashika Ahmed (1) · Edward Parsley, DO (1) · Marvin Konstam, MD (1) · Mordechai Kramer, MD (1)